We are Precision Medicine at UAB.
Precision medicine encompasses the prevention, diagnosis, and treatment of disease when intervention is tailored to individual data characteristics. Precision therapeutics employs genome-directed information, lifestyle, family and medical history in collaboration with physicians to guide patients on their journey to health solutions. The mission of the Hugh Kaul Precision Medicine Institute (PMI) is to support and to accelerate the implementation of precision medical care through research, service, and education.
Our mission is our work.
At PMI, we use data science, bioinformatics, artificial intelligence, and consultation with experts to develop therapeutics strategies to treat genetic disorders including rare disease, cancer, and diabetes. Our experts have developed a logic-driven computer language, known as mediKanren, to access large data sets (PubMed, UniProt, etc.) in order to utilize information in a relationship-based manner, allowing us to quickly link together drugs to genes, or genes to disease. During the COVID-19 pandemic we have leveraged our tools and pivoted our focus to identify readily available, FDA-approved drugs that could be repurposed to prevent and treat SARs-CoV-2.